Oracle’s, Billion

Oracle’s $130 Billion Debt Problem Just Got a $7 Billion Pentagon Patch — And the Market Isn’t Buying It

Published on 07/27/2026 at 03:31 | Redaktion boerse-global.de

Oracle's $7B Pentagon contract fails to lift shares as $130B debt, negative cash flow, and a credit downgrade to near-junk fuel investor anxiety over AI transformation costs.

Oracle Stock Hits 52-Week Low Despite $7B Pentagon Deal Amid Debt and AI Spending Fears
Oracle’s $130 Billion Debt Problem Just Got a $7 Billion Pentagon Patch — And the Market Isn’t Buying It Illustration mit AI erstellt übermittelt durch boerse-global.de

The arithmetic at Oracle has become brutally simple. On Friday, the company booked a cloud and database contract with the Pentagon worth up to $6.99 billion over ten years, with a $3.31 billion base commitment across the first five. It’s the kind of win that should have sent shares climbing. Instead, the stock fell 4.08 percent to close at €101.20 — a new 52-week low and a fresh annual trough that wiped roughly €12 billion from the company’s €303.95 billion market capitalization in a single session.

That single-day loss exceeds the maximum value of the entire Pentagon deal by nearly a factor of two. The message from investors could hardly be clearer: a steady stream of government revenue, even one with the prestige of a Department of Defense seal, is no longer enough to offset the mounting anxiety over how Oracle plans to finance its transformation into an artificial intelligence infrastructure powerhouse.

The Credit Story Overwhelms the Contract Story

The stock now trades 31.64 percent below its 50-day moving average and 36.43 percent below its 200-day moving average. From the September 2025 all-time high, the decline stretches to nearly 64 percent. That is not a garden-variety correction; it is a structural repricing driven by a balance sheet that has investors questioning whether the company can sustain its ambitions.

Oracle’s total debt load is approaching $130 billion. The company recorded negative free cash flow of $23.7 billion in fiscal 2026, a figure that reflects the enormous cost of building out AI-optimized data centers and retooling its workforce — roughly 21,000 jobs have been cut to streamline operations for the new focus. For fiscal 2027, Oracle is reportedly planning a financing package of around $40 billion to keep the expansion rolling.

Should investors sell immediately? Or is it worth buying Oracle?

The credit markets have taken notice. On July 9, 2026, S&P downgraded Oracle’s credit rating to BBB-, just one notch above junk status. The agency cited a persistent underestimation of the company’s capital needs. That downgrade is not merely a headline risk; it raises the cost of servicing existing debt and could force Oracle to suspend share buybacks to preserve cash. It is a second-order effect that no oversold indicator can fix.

A $16.5 Billion Project Stuck in Permitting, a Class Action in the Courts

Operational headwinds compound the financial strain. Oracle’s $16.5 billion AI data center project in New Mexico has stalled amid environmental permitting hurdles, forcing the company into expensive fuel-cell alternatives to meet regulatory requirements. At the same time, a class-action lawsuit is underway accusing Oracle of making misleading statements about the return on capital from its AI investments.

The company is simultaneously raising fresh debt, defending its AI-return narrative in court, and absorbing cost overruns on flagship projects. Against that backdrop, a single Pentagon contract — even one worth nearly $7 billion — looks less like a solution and more like a modest contribution to a much larger problem.

The Bull Case Is Still Alive, But It’s on Probation

The technical picture suggests the selling may have gone too far. The 14-day relative strength index has fallen to 27.6, a level that traditionally signals an oversold condition ripe for a bounce. The average analyst price target stands at $255.57, with a range from $155 to $400, implying upside of roughly 116.5 percent from Friday’s close. Several firms have reaffirmed buy ratings in the past month.

But that consensus masks a deep divide. CLSA recently issued a hold rating with a target well below the market average, arguing that the capital requirements for the AI cloud push are likely to be far higher than what is currently priced in. The wide dispersion in analyst targets — from cautious to wildly optimistic — reflects a fundamental disagreement about how much the financing risk should weigh against the order backlog.

Oracle at a turning point? This analysis reveals what investors need to know now.

Oracle’s annualized volatility sits at 43.81 percent, and with the stock hovering just above its 52-week low, the path ahead promises turbulence in both directions. The oversold RSI argues for a technical rebound. The backlog of contracts argues for the long-term bull thesis. But the downgrade has changed the calculus for anyone betting on a simple mean-reversion trade. Debt-service costs, buyback flexibility, and the pace of capital raising for fiscal 2027 now sit alongside — and arguably above — the growth narrative.

Oracle needs to demonstrate that its AI ambitions can be funded without another credit downgrade. Until then, the stock’s cheapness looks less like an opportunity and more like fair compensation for a balance-sheet risk that isn’t going anywhere.

Ad

Oracle Stock: New Analysis - 27 July

Fresh Oracle information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Oracle analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US68389X1054 | ORACLE’S | boerse | 69881692 |